http://medicalxpress.com/ en-us Medical Xpress internet news portal provides the latest news on Health and Medicine. Focusing prostate cancer testing on men at highest risk of developing the disease is likely to improve the ratio between benefits and the harms of screening, suggests a paper published today in BMJ. http://medicalxpress.com/news/2013-04-deaths-prostate-cancer-age.html Cancer Tue, 16 Apr 2013 18:30:01 EST news285353853 What's most important to a man as he decides whether or not to undergo prostate-specific antigen- PSA- screening for prostate cancer? What does he value most about the screening? And what's the best way to present the information to help him make an appropriate decision for himself? http://medicalxpress.com/news/2013-02-prostate-specific-antigen-screening-values-techniques.html Cancer Mon, 11 Feb 2013 16:40:01 EST news279822719 Measurements taken over time of prostate specific antigen, the most commonly used screening test for prostate cancer in men, improve the accuracy of aggressive prostate cancer detection when compared to a single measurement of PSA, according to a Kaiser Permanente study published today in the British Journal of Urology International. http://medicalxpress.com/news/2013-01-psa-aggressive-prostate-cancer.html Cancer Tue, 15 Jan 2013 11:00:02 EST news277452788 A new research model has estimated that the difference in prostate cancer mortality among men with low-risk disease who choose active surveillance versus those who choose immediate treatment with radical prostatectomy is likely to be very modest, possibly as little as two to three months. http://medicalxpress.com/news/2012-09-surveillance-viable-option-men-low-risk.html Cancer Mon, 24 Sep 2012 13:00:01 EST news267702660 (HealthDay) -- Although the European Randomized Study of Screening for Prostate Cancer (ERSPC) has reported a 29 percent reduction in prostate-cancer mortality for men who undergo prostate-specific antigen (PSA) screening, the benefit is attenuated by loss of quality-adjusted life-years (QALYs) due to post-diagnosis effects, according to a study published in the Aug. 16 issue of the New England Journal of Medicine. http://medicalxpress.com/news/2012-08-benefit-psa-loss-quality-adjusted-life-years.html Cancer Thu, 16 Aug 2012 11:50:02 EST news264332752 Following a period for public comment, the United States Preventive Services Task Force (USPSTF) released its final recommendation for prostate cancer screening. The Task Force now recommends against PSA-based screening for all men, regardless of age. The final recommendations are being published early online in the May 22 issue of Annals of Internal Medicine, the flagship journal of the American College of Physicians (ACP). http://medicalxpress.com/news/2012-05-word-task-psa-based-screening-prostate.html Cancer Mon, 21 May 2012 17:00:01 EST news256823670 Brachytherapy for high-risk prostate cancers patients has historically been considered a less effective modality, but a new study from radiation oncologists at the Kimmel Cancer Center at Jefferson suggests otherwise. A population-based analysis looking at almost 13,000 cases revealed that men who received brachytherapy alone or in combination with external beam radiation therapy (EBRT) had significantly reduced mortality rates. http://medicalxpress.com/news/2012-01-brachytherapy-death-high-risk-prostate-cancer.html Cancer Wed, 25 Jan 2012 17:00:27 EST news246733218 A new study from Harvard School of Public Health (HSPH) and University of California, San Francisco, researchers suggests that men with prostate cancer who smoke increase their risk of prostate cancer recurrence and of dying from the disease. A link also was found between smoking at the time of prostate cancer diagnosis and aggressive prostate cancer, overall mortality (death) and cardiovascular disease mortality. http://medicalxpress.com/news/2011-06-prostate-cancer-recurrence-death.html Cancer Tue, 21 Jun 2011 16:26:17 EST news227892240